Notably, miR-30a was also reported to inhibit cell growth in PCa cells without expressing androgen receptors by targeting MYBL2, FOXD1, and SOX4 [33] and reduced tumorigenicity in vivo models of PCa [34]. The gene discussed is MYBL2; the disease is posterior cortical atrophy.